Shuko Hata - Search Results

Year	Number of Results
2009	2
2010	3
2011	1
2012	4
2013	3
2014	1
2015	4
2016	5
2017	3
2018	3
2019	1
2020	1
2021	3
2022	3
2023	2
2024	0

1

Murakami K, Hata S, Miki Y, Sasano H. Murakami K, et al. Among authors: hata s. Horm Mol Biol Clin Investig. 2018 Feb 28;41(1):/j/hmbci.2020.41.issue-1/hmbci-2017-0081/hmbci-2017-0081.xml. doi: 10.1515/hmbci-2017-0081. Horm Mol Biol Clin Investig. 2018. PMID: 29489455

2

The advantages of co-culture over mono cell culture in simulating in vivo environment.

Miki Y, Ono K, Hata S, Suzuki T, Kumamoto H, Sasano H. Miki Y, et al. Among authors: hata s. J Steroid Biochem Mol Biol. 2012 Sep;131(3-5):68-75. doi: 10.1016/j.jsbmb.2011.12.004. Epub 2012 Jan 9. J Steroid Biochem Mol Biol. 2012. PMID: 22265957 Review.

3

The GR-SGK1-NDRG1 Pathway as a Predictor of Recurrence and Prognosis in Lung Adenocarcinoma After Radical Surgery.

Sasaki T, Nakamura Y, Hata S, Shimada H. Sasaki T, et al. Among authors: hata s. Anticancer Res. 2023 Jul;43(7):2965-2974. doi: 10.21873/anticanres.16467. Anticancer Res. 2023. PMID: 37351994

4

Murine Double Minute 2 Antagonist Nutlin-3 Enhanced Chemosensitivity in Esophageal Squamous Cell Carcinoma.

Ito K, Ishida H, Fujishima F, Nakamura Y, Konno T, Ise K, Hata S, Ozawa Y, Taniyama Y, Kamei T, Sasano H. Ito K, et al. Among authors: hata s. Anticancer Res. 2022 Jun;42(6):2875-2882. doi: 10.21873/anticanres.15769. Anticancer Res. 2022. PMID: 35641284

5

Study of the clinicopathological features of soluble PD-L1 in lung cancer patients.

Sasaki T, Nonomura R, Tabata T, Yoshimura N, Hata S, Shimada H, Nakamura Y. Sasaki T, et al. Among authors: hata s. J Rural Med. 2023 Jan;18(1):42-49. doi: 10.2185/jrm.2022-040. Epub 2023 Jan 6. J Rural Med. 2023. PMID: 36700127 Free PMC article.

6

Expression and clinicopathological significance of glucocorticoid receptor, SGK1, and NDRG1 in hormone-naïve prostate carcinoma.

Hata S, Shimada H, Sato N, Koshiishi M, Ise K, Ogata T, Yamashita S, Ito A, Sasano H, Nakamura Y. Hata S, et al. Med Mol Morphol. 2022 Dec;55(4):283-291. doi: 10.1007/s00795-022-00332-x. Epub 2022 Jul 21. Med Mol Morphol. 2022. PMID: 35861941

7

YM750, an ACAT Inhibitor, Acts on Adrenocortical Cells to Inhibit Aldosterone Secretion Due to Depolarization.

Shimada H, Hata S, Yamazaki Y, Otsubo Y, Sato I, Ise K, Yokoyama A, Suzuki T, Sasano H, Sugawara A, Nakamura Y. Shimada H, et al. Among authors: hata s. Int J Mol Sci. 2022 Oct 24;23(21):12803. doi: 10.3390/ijms232112803. Int J Mol Sci. 2022. PMID: 36361592 Free PMC article.

8

Aromatase in human liver and its diseases.

Hata S, Miki Y, Saito R, Ishida K, Watanabe M, Sasano H. Hata S, et al. Cancer Med. 2013 Jun;2(3):305-15. doi: 10.1002/cam4.85. Epub 2013 Apr 30. Cancer Med. 2013. PMID: 23930207 Free PMC article.

9

PD-L1 Induction by Cancer-Associated Fibroblast-Derived Factors in Lung Adenocarcinoma Cells.

Inoue C, Miki Y, Saito R, Hata S, Abe J, Sato I, Okada Y, Sasano H. Inoue C, et al. Among authors: hata s. Cancers (Basel). 2019 Aug 27;11(9):1257. doi: 10.3390/cancers11091257. Cancers (Basel). 2019. PMID: 31462002 Free PMC article.

10

Tumor microenvironment in invasive lobular carcinoma: possible therapeutic targets.

Nakagawa S, Miki Y, Miyashita M, Hata S, Takahashi Y, Rai Y, Sagara Y, Ohi Y, Hirakawa H, Tamaki K, Ishida T, Watanabe M, Suzuki T, Ohuchi N, Sasano H. Nakagawa S, et al. Among authors: hata s. Breast Cancer Res Treat. 2016 Jan;155(1):65-75. doi: 10.1007/s10549-015-3668-9. Epub 2015 Dec 29. Breast Cancer Res Treat. 2016. PMID: 26715212

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

35 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Results by year